BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments
- 24 June 2008
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (25) , 8766-8771
Abstract
Recent microarray studies with stringent validating criteria identified Bcl-2-associated athanogene ( BAG1 ) as a target for the actions of medications that are mainstays in the treatment of bipolar disorder (BPD). BAG1 is a Hsp70/Hsc70-regulating cochaperone that also interacts with glucocorticoid receptors (GRs) and attenuates their nuclear trafficking and function. Notably, glucocorticoids are one of the few agents capable of triggering both depressive and manic episodes in patients with BPD. As a nexus for the actions of glucocorticoids and bipolar medications, we hypothesized that the level of BAG1 expression would play a pivotal role in regulating affective-like behaviors. This hypothesis was investigated in neuron-selective BAG1 transgenic (TG) mice and BAG1 heterozygous knockout (+/−) mice. On mania-related tests, BAG1 TG mice recovered much faster than wild-type (WT) mice in the amphetamine-induced hyperlocomotion test and displayed a clear resistance to cocaine-induced behavioral sensitization. In contrast, BAG1 +/− mice displayed an enhanced response to cocaine-induced behavioral sensitization. The BAG1 TG mice showed less anxious-like behavior on the elevated plus maze test and had higher spontaneous recovery rates from helplessness behavior compared with WT mice. In contrast, fewer BAG1 +/− mice recovered from helplessness behavior compared with their WT controls. BAG1 TG mice also exhibited specific alterations of hippocampal proteins known to regulate GR function, including Hsp70 and FKBP51. These data suggest that BAG1 plays a key role in affective resilience and in regulating recovery from both manic-like and depression-like behavioral impairments.Keywords
This publication has 34 references indexed in Scilit:
- The FKBP5-Gene in Depression and Treatment Response—an Association Study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) CohortBiological Psychiatry, 2008
- Association of FKBP5 Polymorphisms and Childhood Abuse With Risk of Posttraumatic Stress Disorder Symptoms in AdultsJAMA, 2008
- β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive BehaviorsNeuropsychopharmacology, 2007
- The behavioral actions of lithium in rodent models: Leads to develop novel therapeuticsNeuroscience & Biobehavioral Reviews, 2007
- Bag1 is essential for differentiation and survival of hematopoietic and neuronal cellsNature Neuroscience, 2005
- The Anti-Apoptotic, Glucocorticoid Receptor Cochaperone Protein BAG-1 Is a Long-Term Target for the Actions of Mood StabilizersJournal of Neuroscience, 2005
- The stress system in the human brain in depression and neurodegenerationAgeing Research Reviews, 2005
- Bipolar Disorder and Health-Related Quality of LifePharmacoEconomics, 2005
- Bag1 is a regulator and marker of neuronal differentiationCell Death & Differentiation, 2002
- The Effects of Sertraline and Fluoxetine on Anxiety in the Elevated Plus-Maze TestJournal of Basic and Clinical Physiology and Pharmacology, 2000